A final interesting speculation is that if APP and/or Aβ levels increase in adipose tissue during obesity and AD and coordinated expression is tightly regulated between brain and fat then it is not unreasonable to predict that monitoring APP expression and metabolism in adipose tissue could serve as a surrogate for brain with regard to assessing efficacy of particular drug interventions or monitoring disease pathophysiology of obesity or AD. The gene discussed is APP; the disease is Obesity.